Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2969639 | The Journal of Heart and Lung Transplantation | 2016 | 8 Pages |
Abstract
eGFR is a strong predictor of post-transplant survival and should be considered when assessing patients for OHT. This analysis supports current International Society for Heart and Lung Transplantation guidelines and suggests that end-stage heart failure patients with an eGFR ⤠34 ml/min is a relative contraindication for heart transplantation alone.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kimberly N. MD, MHSA, Aurelie BA, Dhaval MD, Ryan R. MD, Alexander MD, Elizabeth MA, Val MD, Mark J. MD, MS,